Joseph Zeleznik
Joseph Zeleznik is technical product director, IMCD US
Articles
Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing
Krizia M. Karry;Brian Carlin;Nigel Langley;R. Christian Moreton;David Schoneker;Katherine L. Ulman;Joseph Zeleznik
June 13th 2024Key information is needed for excipients and their potential impact on continuous manufacturing processes.
Understanding Concomitant Components in Pharmaceutical Excipients
Jennifer Putnam;Katherine L. Ullman;Priscilla Zawislak;David Schoneker;George Collins;Douglas G. Muse;Brian Carlin;Joseph Zeleznik;R. Christian Moreton
February 3rd 2021Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 22nd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 22nd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 22nd 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 22nd 2024
Exploring Opportunities for LNP Delivery in mRNA
